Clinical manifestations of hospitalized influenza patients without risk factors : A prospective multicenter cohort study in Japan via internet surveillance
Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved..
INTRODUCTION: Influenza remains a clinically heavy burden worldwide. It is well known that some populations are at high risk of complications from influenza, whereas, even previously healthy people might suffer from severe influenza. The objective of this study was to clarify clinical manifestations of hospitalized patients without risk factors infected with influenza.
METHODS: The clinical data for patients who were severely ill with influenza, and required hospitalization were gathered and analyzed between November 2014 and August 2020 (6 influenza seasons) using an internet-surveillance system. Among them, the patients who had no risk factors of complications from influenza were extracted.
RESULTS: Finally, a total of 91 patients (9.0% of all influenza-related hospitalizations) without risk factors were analyzed. The no risk group was younger than the risk group, though other significant differences of clinical characteristics were not recognized between the groups. Pneumonia was the most common cause of hospitalization in the no risk group, and primary influenza viral pneumonia was the most common pneumonia. Antiviral drugs were administered in 96.7% of the no-risk group, and artificial ventilation was performed in 18.7%. In-hospital death was recorded for 3 patients without risk factors.
CONCLUSIONS: Severe complications of influenza which required hospitalization may occur in a certain degree of patients with no risk factors. Efforts are needed to diagnose and treat influenza appropriately even in previously healthy younger patients. Continuous nationwide surveillance will be required to clarify risk factors for severe influenza even in previously healthy younger patients. (UMIN000015989).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 28(2022), 7 vom: 01. Juli, Seite 853-858 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ishida, Tadashi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Hospitalization |
|---|
| Anmerkungen: |
Date Completed 12.05.2022 Date Revised 12.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jiac.2022.02.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM339908866 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM339908866 | ||
| 003 | DE-627 | ||
| 005 | 20231226003937.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jiac.2022.02.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1132.xml |
| 035 | |a (DE-627)NLM339908866 | ||
| 035 | |a (NLM)35461771 | ||
| 035 | |a (PII)S1341-321X(22)00042-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ishida, Tadashi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical manifestations of hospitalized influenza patients without risk factors |b A prospective multicenter cohort study in Japan via internet surveillance |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.05.2022 | ||
| 500 | |a Date Revised 12.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a INTRODUCTION: Influenza remains a clinically heavy burden worldwide. It is well known that some populations are at high risk of complications from influenza, whereas, even previously healthy people might suffer from severe influenza. The objective of this study was to clarify clinical manifestations of hospitalized patients without risk factors infected with influenza | ||
| 520 | |a METHODS: The clinical data for patients who were severely ill with influenza, and required hospitalization were gathered and analyzed between November 2014 and August 2020 (6 influenza seasons) using an internet-surveillance system. Among them, the patients who had no risk factors of complications from influenza were extracted | ||
| 520 | |a RESULTS: Finally, a total of 91 patients (9.0% of all influenza-related hospitalizations) without risk factors were analyzed. The no risk group was younger than the risk group, though other significant differences of clinical characteristics were not recognized between the groups. Pneumonia was the most common cause of hospitalization in the no risk group, and primary influenza viral pneumonia was the most common pneumonia. Antiviral drugs were administered in 96.7% of the no-risk group, and artificial ventilation was performed in 18.7%. In-hospital death was recorded for 3 patients without risk factors | ||
| 520 | |a CONCLUSIONS: Severe complications of influenza which required hospitalization may occur in a certain degree of patients with no risk factors. Efforts are needed to diagnose and treat influenza appropriately even in previously healthy younger patients. Continuous nationwide surveillance will be required to clarify risk factors for severe influenza even in previously healthy younger patients. (UMIN000015989) | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Hospitalization | |
| 650 | 4 | |a Influenza | |
| 650 | 4 | |a No risk factors | |
| 650 | 4 | |a Previously healthy | |
| 700 | 1 | |a Seki, Masafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Oishi, Kazunori |e verfasserin |4 aut | |
| 700 | 1 | |a Tateda, Kazuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Fujita, Jiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kadota, Jun-Ichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kawana, Akihiko |e verfasserin |4 aut | |
| 700 | 1 | |a Izumikawa, Koichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kikuchi, Toshiaki |e verfasserin |4 aut | |
| 700 | 1 | |a Ohmagari, Norio |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Mitsuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Maruyama, Takaya |e verfasserin |4 aut | |
| 700 | 1 | |a Takazono, Takahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Miki, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Miyazaki, Yoshitsugu |e verfasserin |4 aut | |
| 700 | 1 | |a Yamazaki, Yoshitaka |e verfasserin |4 aut | |
| 700 | 1 | |a Kakeya, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ogawa, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Nagai, Hideaki |e verfasserin |4 aut | |
| 700 | 1 | |a Watanabe, Akira |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |d 1996 |g 28(2022), 7 vom: 01. Juli, Seite 853-858 |w (DE-627)NLM095488073 |x 1437-7780 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2022 |g number:7 |g day:01 |g month:07 |g pages:853-858 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jiac.2022.02.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2022 |e 7 |b 01 |c 07 |h 853-858 | ||